Nitrotyrosine, Nitrated Lipoproteins, and Cardiovascular Dysfunction in Patients with Type 2 Diabetes: What Do We Know and What Remains to Be Explained?
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.